Research and Markets: Global TB Diagnostic Market to Grow at a CAGR of 2.97% During the Period 2014-2019, New Report Says

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/4rlt4m/global_tb) has announced the addition of the "Global TB Diagnostic Market 2015-2019" report to their offering.

Developments in the diagnostic paradigm and increased allocation of funds and resources have led to the manufacture of new technologies for TB diagnosis. These innovative technologies help to make disease diagnosis rapid and accurate. For instance, the WHO recommends Xpert MTB/RIF for disease diagnosis as the equipment provides improved accuracy and test sensitivity. In 2013, rapid tests were used to diagnose TB in 58% of the 4.9 million individuals with pulmonary TB. Various non-profit organizations are now funding high-burden low-income countries to use these rapid tests. High- and moderate-burden countries, such as South Africa and Brazil, have also intensified their research on molecular diagnostics to develop rapid tests.

According to the report, the WHO identifies 22 nations, including India, China, and South Africa, as high-burden countries. The high prevalence of the disease has increased the demand for early diagnosis and detection tools. Many countries implement innovative strategies to address market needs, such as public awareness programs and the launch of fast, accurate, and early diagnostics, resulting in a decline in disease incidence rates. Diagnosing infection and drug-resistant TB is a major factor hindering the market growth.

Key Topics Covered

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Market Landscape
  7. Prevalence and Incidence Rate
  8. Advances in Technology
  9. TB Diagnostics Pipeline
  10. Market Segmentation by Disease Stage
  11. Geographical Segmentation
  12. Buying Criteria
  13. Market Growth Drivers
  14. Drivers and Their Impact
  15. Market Challenges
  16. Impact of Drivers and Challenges
  17. Market Trends
  18. Trends and Their Impact
  19. Vendor Landscape
  20. Key Vendor Analysis

Companies Mentioned

- Abbott

- Alere

- Alere US

- Becton

- BioMérieux

- Cepheid

- Dickinson

- Eiken Chemical Japan

- Epistem UK

- F. Hoffmann-La Roche

- Hain Lifescience

- Hologic

- Ortho Clinical

- Siemens

For more information visit http://www.researchandmarkets.com/research/4rlt4m/global_tb

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics